Primary Site >> Stomach Cancer

Gene >> CYP2C19

Journal: World J Gastroenterol. 2004 Jul 1;10(13):1961-3.
Title: Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population.
Author: Shi, Wei-Xing|Chen, Shu-Qing
PMID: 15222046
Journal: Aliment Pharmacol Ther. 2005 Nov 15;22(10):1033-40.
Title: Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection.
Author: Sugimoto, M|Furuta, T|Shirai, N|Nakamura, A|Kajimura, M|Sugimura, H|Hishida, A|Ishizaki, T
PMID: 16268979
Journal: Clin Gastroenterol Hepatol. 2005 Dec;3(12):1180-6.
Title: Gastroduodenal disease, Helicobacter pylori, and genetic polymorphisms.
Author: Gillen, Derek|McColl, Kenneth E L
PMID: 16361041
Journal: Korean J Gastroenterol. 2006 Mar;47(3):181-90.
Title: [Clinical use of proton pump inhibitors in gastrointestinal diseases].
Author: Rew, Jong Sun
PMID: 16554671
Journal: Int J Gastrointest Cancer. 2006;37(1):1-5.
Title: CYP2C19 polymorphisms in patients with gastric and colorectal carcinoma.
Author: Tamer, L|Ercan, B|Ercan, S|Ates, N|Ates, C|Ocal, K|Dirlik, M|Aydin, S|Atik, U
PMID: 17290075
Journal: PLoS One. 2013 Aug 27;8(8):e73126.
Title: Poor metabolizers at the cytochrome P450 2C19 loci is at increased risk of developing cancer in Asian populations.
Author: Wang, Hong|Song, Kang|Chen, Zenggan|Yu, Yanmin
PMID: 24015291
Journal: Asian Pac J Cancer Prev. 2014;15(22):9909-13.
Title: Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Author: Srinarong, Chanagune|Siramolpiwat, Sith|Wongcha-um, Arti|Mahachai, Varocha|Vilaichone, Ratha-korn
PMID: 25520127
Journal: Asian Pac J Cancer Prev. 2014;15(24):10957-60.
Title: Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer.
Author: Jainan, Wannapa|Vilaichone, Ratha-Korn
PMID: 25605208
Journal: Asian Pac J Cancer Prev. 2017 Apr 1;18(4):927-932.
Title: Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication
Author: Chunlertlith, Kitti|Limpapanasit, Uaepong|Mairiang, Pisaln|Vannaprasaht, Suda|Tassaneeyakul, Wichittra|Sangchan, Apichat|Sawadpanich, Kookwan|Suttichaimongkol, Tanita|Pongpit, Jamrus|Pattarapongsin, Moragot
PMID: 28545189
Journal: Asian Pac J Cancer Prev. 2017 Oct 26;18(10):2839-2843.
Title: Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study
Author: Chotivitayatarakorn, Peranart|Mahachai, Varocha|Vilaichone, Ratha-Korn
PMID: 29072432
Journal: Oncol Lett. 2018 Oct;16(4):4489-4497.
Title: Influence of SLCO1B1 in gastric cancer patients treated with EOF chemotherapy.
Author: Feng, Wanjing|Liu, Xin|Zhao, Xiaoying|Huang, Mingzhu|Guo, Weijian|Yin, Jiliang|Chen, Zhiyu|Zhu, Xiaodong
PMID: 30214584